CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Systemic Corticosteroids Avoidance Study in Severe Asthma Patients [Phase 3]
Summary
Phase 3 trial studying avoidance of systemic corticosteroids in patients with severe asthma was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: TERMINATED | Results posted: 2021-02-02